Outcome of Incidental Pulmonary Nodules in a Real-World Setting

被引:2
|
作者
Vindum, Helene Hjorth [1 ]
Kristensen, Katrine [1 ,4 ]
Christensen, Niels Lyhne [1 ,2 ]
Madsen, Hans Henrik [3 ]
Rasmussen, Torben Riis [1 ,2 ]
机构
[1] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
[2] Aarhus Univ, Inst Clin Med, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Radiol, Aarhus, Denmark
[4] Aarhus Univ Hosp, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark
关键词
CT follow-up program; CT guided needle biopsy; Early detection; IPN; Malignancy; LUNG-CANCER;
D O I
10.1016/j.cllc.2023.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Incidental pulmonary nodules (IPN) may represent early stages of lung cancer. Our retrospective cohort study of 4181 patients in a CT IPN follow-up program from 2018 to 2021 at Aarhus University Hospital shows an incidence of lung cancer of 6%, predominantly in curable stages. Of the entire CT IPN population 4.5% under-went CT guided needle biopsy without the detection of malignancy. Objectives: Early diagnosis of lung cancer is imperative to improve survival. Incidental pulmonary nodules (IPN) may represent early stages of lung cancer and appropriate follow-up and management of these nodules is important, but also very resource demanding. We aim to describe the results of the CT-based follow-up on a cohort of patients with IPN in terms of detected malignancies, the proportion undergoing invasive procedures, and the subsequent outcome. Materials and Methods: Retrospective cohort study of patients in a CT IPN follow-up program who underwent a needle biopsy of the lung from 2018 to 2021 at Aarhus University Hospital. Results: A total of 4181 patients with IPN were followed with CT control scans. Out of these 249 (6%) were diagnosed with lung cancer of which 224 (90%) were diagnosed as a result of the IPN follow-up. Seventy-five percent of the patients were diagnosed in stages I to II and curable treatment was possible in 77.9% of the patients. In the CT IPN follow-up program 449 patients underwent a CT guided needle biopsy. Out of these 190 patients underwent biopsy without the detection of malignancy, corresponding to 4.5% of the entire IPN population. Conclusion: The cumulated incidence of lung cancer in our population in the IPN follow-up program was 6%. The probability of malignancy when undergoing an invasive procedure on an IPN was 55.7% of which lung cancer was vastly predominant. The majority of lung cancers were diagnosed in an early and potentially curable stage.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 50 条
  • [41] Tigecycline-associated hypofibrinogenemia in a real-world setting
    Campany-Herrero, David
    Larrosa-Garcia, Maria
    Lalueza-Broto, Pilar
    Rivera-Sanchez, Lucas
    Espinosa-Pereiro, Juan
    Mestre-Torres, Jaume
    Pigrau-Serrallach, Carles
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (04) : 1184 - 1189
  • [42] The Challenge of Assessing Treatment Effectiveness in a Real-World Setting
    Smith, Alexandra
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 2026 - 2029
  • [43] Midterm Survival Results of Preserflo in a Real-World Setting
    Lima-Cabrita, Afonso
    Santos, Miguel
    Jose, Patricia
    Barao, Rafael
    Barata, Andre
    Pinto, Luis Abegao
    JOURNAL OF GLAUCOMA, 2024, 33 (11) : 880 - 887
  • [44] Effectiveness of Bisphosphonate Therapy in a Real-World Setting.
    Feldstein, A. C.
    Weycker, D.
    Nichols, G. A.
    Oster, G.
    Rosales, G.
    Perrin, N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S463 - S463
  • [45] Denosumab and Mortality in a Real-World Setting: A Comparative Study
    Alarkawi, Dunia
    Tran, Thach
    Chen, Weiwen
    March, Lyn M.
    Blyth, Fiona M.
    Blank, Robert D.
    Bliuc, Dana
    Center, Jacqueline R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (12) : 1757 - 1770
  • [46] The Use of Biologics in a Real-world Setting Reduces Hospitalizations
    Mallozzi, M.
    Pena, D. E.
    Roman, J.
    Most, J. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [47] Efficacy and tolerability of teriflunomide in a real-world clinical setting
    Duquette, P.
    Roger, E.
    Nadeau, N.
    Hum, S.
    Bigras, C.
    Despault, P.
    Lapierre, Y.
    Grand'Maison, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 245 - 246
  • [48] Adherence to anticoagulant treatment with dabigatran in a real-world setting
    Schulman, S.
    Shortt, B.
    Robinson, M.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 954 - 954
  • [49] Drug survival of secukinumab for psoriasis in a real-world setting
    Lee, Erica B.
    Amin, Mina
    Egeberg, Alexander
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 150 - 151
  • [50] Pharmacovigilance in a real-world data setting - a comparative study
    Mouresan, Elena Flavia
    Forsberg, Lars
    Glaser, Anna
    Hillert, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 659 - 660